The naphthylacetic acid-modified GFFY (Nap-GFFY) also is a novel vaccine adjuvant, antigens can be easily incorporated into the hydrogel by a vortex or by gently shaking before injection, and the vaccines can stimulate strong CD8+ T-cell responses, which significantly inhibits tumor growth.27 Here, CD8A is linked to neoplasm.